PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Biotechnology and pharmaceutical companies - Market size and forecast 2018-2023 • Hospitals and diagnostic centers - Market size and forecast 2018-2023 • Academic institutes and research organizations - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Rising use of molecular biology kits for disease diagnosis • Increasing number of applications of molecular biology • enzymes, kits, and reagents • Technological advances in the life sciences industry PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agilent Technologies, Inc. • F. Hoffmann-La Roche Ltd • Illumina, Inc. • Merck KGaA • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Biotechnology and pharmaceutical companies - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Biotechnology and pharmaceutical companies - Year-over-year growth 2019-2023 (%) Exhibit 21: Hospitals and diagnostic centers - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Hospitals and diagnostic centers - Year-over-year growth 2019-2023 (%) Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Agilent Technologies, Inc. - Vendor overview Exhibit 46: Agilent Technologies, Inc. - Business segments Exhibit 47: Agilent Technologies, Inc. - Organizational developments Exhibit 48: Agilent Technologies, Inc. - Geographic focus Exhibit 49: Agilent Technologies, Inc. - Segment focus Exhibit 50: Agilent Technologies, Inc. - Key offerings Exhibit 51: F. Hoffmann-La Roche Ltd - Vendor overview Exhibit 52: F. Hoffmann-La Roche Ltd - Business segments Exhibit 53: F. Hoffmann-La Roche Ltd - Organizational developments Exhibit 54: F. Hoffmann-La Roche Ltd - Geographic focus Exhibit 55: F. Hoffmann-La Roche Ltd - Segment focus Exhibit 56: F. Hoffmann-La Roche Ltd - Key offerings Exhibit 57: Illumina, Inc. - Vendor overview Exhibit 58: Illumina, Inc. - Product segments Exhibit 59: Illumina, Inc. - Organizational developments Exhibit 60: Illumina, Inc. - Geographic focus Exhibit 61: Illumina, Inc. - Segment focus Exhibit 62: Illumina, Inc. - Key offerings Exhibit 63: Merck KGaA - Vendor overview Exhibit 64: Merck KGaA - Business segments Exhibit 65: Merck KGaA - Organizational developments Exhibit 66: Merck KGaA - Geographic focus Exhibit 67: Merck KGaA - Segment focus Exhibit 68: Merck KGaA - Key offerings Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 70: Thermo Fisher Scientific Inc. - Business segments Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings Exhibit 75: Validation techniques employed for market sizing

Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd Illumina, Inc. Merck KGaA Thermo Fisher Scientific Inc.